High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

By B. Warren, A. Eid, P. Singer, S. Pillay, P. Carl, I. Novák, P. Chalupa, A. Atherstone, I. Pénzes, A. Kübler and 7 more. 2001

1,251 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Hematology

View Paper: https://www.semanticscholar.org/paper/d756d3af39cc773d96e2aafd4d07769220e89cac

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. Mitchell M. Levy
2. Jean-Louis Vincent
3. Derek C. Angus

In Epidemiology

1. Jean-Louis Vincent
2. Mitchell M. Levy
3. Derek C. Angus
4. Mervyn Singer
5. A. Rhodes
6. Laura Evans
7. G. Ramsay
8. Janice L. Zimmerman

In Hematology

1. C. Esmon

Citations in the corpus

• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, background): “Antithrombin was associated with an increased risk of bleeding [340, 341].”
• Guidelines for the diagnosis and management of disseminated intravascular coagulation (2009, neutral): “A large-scale multicentre randomised controlled trial to directly assess the effect of antithrombin concentrate on mortality in septic patients also showed no significant reduction in those treated with antithrombin concentrate (Warren et al , 2001).”
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (2004, background): “High-dose antithrombin was associated with an increased risk of bleeding when administered with heparin (59).”
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (2013, background): “High-dose antithrombin was associated with an increased risk of bleeding when administered with heparin [206].”